From May 8-10, 2025, a distinguished Chinese delegation, led by Professor Ying Wang, Vice President of China Anti-Cancer Association (CACA), attended the 22nd World Congress on Breast Cancer & Breast Healthcare and the 12th Caribbean Breast Symposium in Puerto Rico. Hosted by the Senologic International Society (SIS), this premier event brought together leading global experts in breast health.
Founded in 1976 by Dr. Charles-Marie Gross, a pioneer in modern breast imaging, in Strasbourg, France, SIS is the world's first international academic organization dedicated to breast cancer diagnosis and treatment. Committed to integrating global resources to advance breast health, SIS has grown into a prestigious international network spanning five continents with over 100 member societies.
◆**China Secures Hosting Rights for 23rd SIS World Congress on Breast Health**
Under the active promotion of SIS Council Member Prof. Xishan Hao, the 23rd World Congress on Breast Cancer & Breast Healthcare will be held in Tianjin, China from May 8-10, 2026. The congress is jointly organized by SIS and CACA, with Tianjin Medical University Cancer Institute & Hospital serving as the host institution.
At the opening ceremony, Vice President Ying Wang, on behalf of Prof. Xishan Hao, delivered a keynote address for the organizing committee. She highlighted CACA's remarkable achievements in recent years, including academic exchanges, guideline promotion, public education, and international collaboration, emphasizing its pivotal role in China's cancer prevention and control efforts.
She also introduced the congress host—Tianjin Medical University Cancer Institute & Hospital, the birthplace of China's oncology medicine. As home to Asia's largest breast cancer research and treatment center, the hospital leads the nation in breast cancer prevention, diagnosis, treatment, and research.
A promotional video showcased Tianjin's rich cultural heritage, inclusive spirit, and the hospital's developmental journey, earning widespread acclaim from attendees. Global experts expressed great anticipation for the 2026 gathering in Tianjin.
◆**Academic Feast: Cutting-Edge Exploration and Intellectual Exchange**
The congress brought together world-renowned experts in breast health, covering key topics including early breast cancer screening, precision therapy, genetic testing, and AI applications. Professor Vahit Ozman, President of SIS, reviewed the historical development of breast cancer diagnosis and treatment, while Congress Chair Prof. Bolivar Arboleda-Osorio presented the evolution of breast cancer technologies through a journey across time. Distinguished American scholars shared pioneering concepts integrating medical innovation with artistic expression.
Representing China, Prof. Hong Liu, Prof. Jinpu Yu, and Prof. Yehui Shi from Tianjin Medical University Cancer Institute & Hospital delivered insightful keynote presentations and chaired specialized sessions, showcasing China's latest advancements in breast cancer treatment and research. Their scientific achievements and academic perspectives received unanimous recognition from international peers, further demonstrating China's growing influence in the global breast health community.
◆**The Flag-Handing Ceremony: Passing the Torch to a New Chapter**
A solemn flag-handing ceremony marked a pivotal moment during the congress. Prof. Bolivar Arboleda-Osorio, Chair of the 22nd Congress, ceremoniously presented the SIS flag to the Chinese delegation, symbolizing the official transfer of hosting rights for the 23rd Congress.
Current SIS President Prof. Vahit Ozman and President-Elect Prof. Carole Mathelin expressed their full support for China hosting the next congress, sharing their anticipation for a successful 2026 event.
On behalf of CACA, Prof. Ying Wang delivered an address congratulating the successful hosting of the current congress in Puerto Rico. She affirmed China's commitment to incorporating valuable experiences from this event and pledged to collaborate with Tianjin Medical University Cancer Institute & Hospital to deliver an exceptional academic gathering for the global breast health community.
The ceremony represented both an honor and a responsibility, as China prepares to build upon SIS's legacy while showcasing its own advancements in breast cancer research and treatment on the world stage. This transition underscores the increasingly important role of international cooperation in advancing global breast health standards.
◆**Deepening Collaboration: Jointly Mapping the Future of Breast Health**
During the conference, the Chinese delegation engaged in multiple high-level exchanges with international experts, conducting in-depth discussions on collaborative opportunities in breast health. These meaningful dialogues established a solid foundation for future multinational research initiatives and global partnerships.
This participation not only showcased China's remarkable achievements in breast cancer prevention and treatment, but also demonstrated our nation's open attitude in actively engaging with global health governance. In 2026, Tianjin will welcome colleagues from around the world with both warmth and professionalism as we jointly compose a new chapter in breast health advancement!
Tianjin Welcomes You in 2026!
